ABSTRACT. Vascular dopamine (DAI) receptors may modulate circulatory hemodynamics in lambs. We evaluated resting dopaminergic tone in lambs by pharmacologically manipulating peripheral DAI receptors with i.v. SCH 23390, (a highly selective, competitive DAI receptor antagonist) and i.v. fenoldopam, (a highly selective DAI receptor agonist) in unanesthetized lambs, instrumented for circulatory studies, while measuring the systemic and pulmonary vascular changes that the manipulations induced. We examined both the independent effects of DAI receptor stimulation and blockade as well as the effects of the agonist and the antagonist infused together (competitive interaction). SCH 23390, infused at 2.5 pg/kg.min-I, caused significant increases in left atrial, systemic, and pulmonary artery pressure, as well as an increase in systemic vascular resistance and a decrease in heart rate. Fenoldopam, infused at the dose of 60 pg/kg. min-' caused significant decreases in mean systemic artery pressure and systemic vascular resistance while increasing cardiac index and mean pulmonary artery pressure. SCH 23390 blunted the fenoldopam-induced effects. Our data suggest that dopaminergic influence may be active in the maintenance of resting hemodynamics of the lamb. (Pediatr Res 33: 181-184, 1993) Abbreviations models (6), which does not address the role of dopaminergic function under normal physiologic states.
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Dopamine concentrations in amniotic fluid and in plasma of fetuses are higher than plasma levels in adults (7. 8) . These data provide some indirect evidence that endogenous dopamine is important in the fetus and newborn. Studies investigating dopamine receptor density and affinity in the fetal and newborn kidney. as well as studies examining the physiologic responses to dopaminergic stimulation in fetal and newborn animals. have not provided a concise answer, though they also point to a role of dopamine as a factor in fetal development (9-1 1). Most of this research has focused on renal tubular effects of dopamine. though vasodilating dopamine receptors are also present in mesenteric, coronary, and pulmonary vascular beds (6, 12, 13) of adult animals. Weir (14) has postulated that in the pulmonary circulation, the normal. low vascular tone is the active phase of the vascular response. If the factors causing the vasodilation are removed, vasoconstriction results (14) . It is possible that active vasodilation also occurs in the systemic circulation where. as suggested by Bell ( 1 5). endogenous dopamine has a physiologic function in control of blood volume and blood pressure. Defects in the dopaminergic system may play an important role in the etiology of hypertensive states ( 16). Vascular receptors mediating vasodilation, such as DAI, may play a significant role in the maintenance of the vascular hemodynamics, especially for the fetus and during the transitional circulation period of the newborn. DAI, postsynaptic, vascular dopamine receptor We hypothesized that if systemic and pulmonary DAI recep-PAP, mean pulmonary artery pressure tors are chronically occupied by endogenous dopamine. the LAP, mean left atrial pressure application of a receptor antagonist would "turn off' the active SAP, mean systemic artery pressure vasodilation and lead to observable hemodynamic alterations. QP, pulmonary blood flow We studied this hypothesis by selectively blocking peripheral SVR, systemic vascular resistance DA, receptors with the highly specific. competitive DAI receptor PVR, pulmonary vascular resistance antagonist, SCH 23390. We also infused the selective DAI agonist, fenoldopam, alone and in combination with SCH 23390. These compounds were infused into healthy. unanesthetized lambs instrumented for circulatory studies. We report the effects of these vascular DAI receptor manipulations. A wide variety of responses are evoked by infused dopamine. This occurs because the hernodynamic effects of dopamine recep-MATERIALS A N D METHODS tor stimulation are obscured by simultaneous stimulation of nand 8-adrenergic receptors ( I ) . Thus, the unique contribution of Twelve mixed-breed lambs. I to 3 d old. were instrumented dopamine receptors to overall circulatory dynamics has been in the following manner. Polyethylene catheters were placed in difficult to discern. The availability of selective dopamine recep-the inferior vena cava and descending aorta by cutdown of the tor agonists and antagonists has greatly increased our understand-hindlimb. Then, via a left lateral thoracotomy, an electromaging of the function of vascular dopamine receptors. Much of the netic flow tm~sducer was placed around the main ~u l m o n a~ research has dealt with manipulation of dopamine receptors in artery; catheters were placed into the main pulmonary artery disease states (2. 3) or acute anesthetized (4, 5) or isolated organ (distal to the flow transducer) and into the left atrium, and the ductus arteriosus was ligated. The catheters and flow probe cable POLAK AND DRUMMOND 14 d of age. All experiments were performed while the lambs were suspended upright in a sling. spontaneously breathing room air. All procedures were performed in accordance with National Institutes of Health animal utilization policies. During the experiments. we measured systemic and pulmonary vascular pressures and left atrial pressures using Could-Brush PB23 10 transducers and a Could 2800 physiologic recorder. We measured pulmonary blood flow using a Could-Statham SP2202 flow meter interfaced to the physiologic recorder.
We measured mean PAP, SAP. LAP, QP. and heart rate in all lambs. Because the ductus arteriosus was ligated in all lambs, pulmonary blood flow equalled cardiac output. We calculated PVR; PVR = (PAP -LAP)/QP. kg-'. SVR was calculated using the formula SVR = SAP/QP.kg-I, assuming that right atrial pressure was negligible compared with systemic pressure.
SCH 23390 (Schering Corporation, Bloomfield, NJ), is a highly specific. competitive DAl receptor antagonist (5. 17-19) . Renal DAI receptors in the dog have been completely blocked by a dose as low as 0.5 pg/kg.min-I, whereas DAl selectivity is retained at doses up to 30 pg/kg.min-I. For this experiment. we chose to infuse the SCH 23390 at a dose of 2.5 pg/kg.min-I. which was derived from studies previously reported (5, (17) (18) (19) and pilot studies from our lab. SCH 23390 is considered to be the gold standard for both pharmacologic blockade of DAI receptors and. in a tritiated form, for dopamine receptor identification (20) , though experience with this compound in lambs is somewhat limited ( I I , 21).
Fenoldopam mesylate (SKF-82526; Smith, Kline, and Beecham Laboratories, Philadelphia, PA) is a benzapine compound developed as an antihypertensive agent. It is a selective DAI agonist at doses from 0.1 to 100 pg/kg.min-' (4, 22) . A dose of 60 pg/kg. min-I was chosen based on data from our lab showing significant alterations in hemodynamic variables. presumably via stimulation of DAI receptors (23) .
For both drugs, physiologic saline was used as the vehicle. All drug infusions were into the inferior vena cava. The experimental protocols are outlined in Figure 1 . On 2 separate d. each lamb received either an infusion of saline (control) and fenoldopam. or SCH 23390 and fenoldopam. As such. we were able to examine the independent effects of DAI receptor stimulation and blockade as well as the effects of the agonist and the antagonist infused together.
Each study began with a 20-min baseline period. during which time the lamb acclimated to the sling and laboratory environment. Baseline hemodynamic variables were recorded at the end of this period. and arterial blood was sampled for pH, arterial 0 2 tension, and arterial COz tension. We then started an infusion of either SCH 23390 at 2.5 pg/kg.min-I or an equivalent volume of physiologic saline. Changes in physiologic measurements were recorded. and an arterial blood gas was obtained 10 min from the start of the antagonist infusion. At this time, fenoldopam at 60 pg/kgmin-' was infused into the lamb. Changes in physiologic measurements were recorded, and an arterial blood gas was obtained 10 min from the start of the agonist infusion. The continuously measured physiologic variables (PAP, LAP, SAP, heart rate, QP/kg) and the calculated data (SVR, PVR) from baseline verszrs DAI blockade with SCH 23390 and from baseline verszls DAI stimulation with fenoldopam were compared and analyzed by a single-factor, repeated-measures analysis of variance. Changes in physiologic parameters as a result of simultaneous infusion of fenoldopam and SCH 23390 were recorded and compared with baseline, fenoldopam alone, and SCH 23390 alone. These data were analyzed by multifactor analysis of variance. All data are presented as mean + SD. The a level of significance wasp < 0.05.
RESULTS
For all experiments, the lambs maintained normal behavior and respiration (60 + 15 breathslmin). Arterial blood gas measurements also remained stable throughout all experiments: pH 7.38 + 0.04, arterial Oz tension 8 1.0 + 10.0 mm Hg (10.8 + 1.3 kPa), and arterial COz tension 36.0 + 5.0 mm Hg (4.8 + 0.7 kPa). The systemic and pulmonary artery pressure and left atrial pressure are detailed in Figure 2 . Heart rate, cardiac index, and stroke volume as well as pulmonary and systemic vascular resistance from the four groups are detailed in Table 1. SCH 23390 infusion. Cardiac index was unaffected by SCH 23390 infusion. Heart rate decreased, whereas significant increases in stroke volume, systemic and pulmonary artery pressure, left atrial pressure, PVR, and SVR were noted.
Fenoldopam infusion. Fenoldopam, infused at the dose of 60 &kg. min-I, caused significant decreases in systemic artery pressure and SVR while increasing cardiac index, heart rate, stroke volume, and pulmonary artery pressure. PVR was unaffected. I~c~noldopum + SCH 23390. Simultaneous infusion of fenoldopam and SCH 23390 tended to attenuate the independent effects of both compounds. As a result of this competitive interaction. heart rate. systemic artery pressure, and SVR and PVR returned to baseline values. Values for cardiac index, stroke volume, pulmonary artery pressure, and left atrial pressure were between those of fenoldopam infused alone and SCH 23390 infused alone.
DISCUSSION
The chronically instrumented animal offers an excellent model for demonstration of pharmacologic manipulation of normal physiology. The setting is uncomplicated by the stress associated with general anesthesia and acute surgical intervention (24) , and the lambs are trained to accept handling and are calm and unstressed during the experiments. Experimental results are therefore a reflection of a normal hemodynamic state with multisystem interactions that are impossible to reproduce with other experimental models.
The renal, mesenteric. coronary, and pulmonary vascular beds of mammals are populated with D A I receptors (6, 12, 13) . Our data suggest that these receptors may be occupied chronically, providing a degree of vasodilation to maintain resting systemic and pulmonary pressure. As demonstrated from our data, blockade of these active, vasodilating receptors results in vasoconstriction with an elevation in systemic and pulmonary artery pressures, and SVR and PVR. This increase in SVR and subsequent increase in left ventricular afterload leads to an increase in left atrial pressure. A significant decrease in heart rate, which may be secondary to baroreflex mechanisms, was also noted.
Infusion of fenoldopam causes hemodynamic alterations that can, for the most part, be explained by DA, receptor-induced vasodilation. Systemic arterial pressure and SVR drops. The significant increase in heart rate, cardiac index. and stroke volume with fenoldopam suggests that dopamine receptor stimulation exerts a chronotropic and ionotropic effect either directly or via secondary release of catecholamines. The increase in pulmonary artery pressure without a change in PVR is most likely the indirect result of increased QP and heart rate.
The effects of infusion of both agonist and antagonist represent a competitive receptor-ligand interaction. The wide range of hemodynamic responses. some attenuated toward baseline values, some closer to agonist responses. and some closer to antagonist-induced responses, suggest that perhaps DAI receptors vary in affinity to SCH 23390 and/or fenoldopam. This possibility is consistent with recent studies demonstrating at least three different subtypes of the DAI receptor (25) .
Control of systemic and pulmonary vascular tone in the fetus and newborn is not dictated by any single mechanism. Research has indicated that fetal and newborn hemodynamics may be influenced by a variety of factors that are different from those in the adult (26) (27) (28) (29) . Some of the many factors involved in the control of systemic and pulmonary vascular dynamics include endothelial factors (endothelial-derived relaxing factor and endothelin), vasoactive compounds such as bradykinin and products of arachidonic acid metabolism, vasoactive peptides produced in the heart, and hypothalamus (vasopressin), and environmental factors (normoxia, hypoxia, pH). All of these factors and mechanisms of action seem to interact in the normal maintenance of systemic and pulmonary vascular tone in both normal and abnormal conditions.
There is increasing evidence that the dopamine-dopaminergic receptor system also contributes to the active maintenance of fetal and newborn hemodynamics, which continues into adult life (9-1 1,30). The most important role of dopamine in the fetus is control of renal function, primarily by affecting sodium excretion. These dopamine-receptor interactions are at the tubular level, with dopamine produced locally. The role of endogenous dopamine and vascular dopamine receptors in the fetus and newborn and their contribution to maintaining the hemodynamic state is not clear. Nakamura rt ul. (30) demonstrated an increase in renal blood flow with infused dopamine (with a-and P-adrenoreceptor blockade) in fetal, newborn, and adult sheep. though this effect has not been seen in all species (3 1-32). Results from these studies do not directly correlate to normal physiology. Though plasma dopamine concentrations in the fetus and newborn are increased compared with adult levels (7, 8) . they are certainly lower than levels achieved with these pharmacologic studies of dopamine. A dopaminergic role in systemic and/or pulmonary hemodynamics must therefore rely upon release of endogenous dopamine from adrenergic/dopaminergic nerve endings or direct tissue production.
We chose to approach the question of vascular dopaminergic function in newborns by examining both the DA, antagonist, SCH 23390, and the selective DA, agonist, fenoldopam, in a chronically instrumented, unanesthetized lamb model. This agonist-antagonist pair provides a powerful tool for delineating functional activity of dopamine receptors (6, 33) . Our data show a clear pharmacologic importance of vascular dopamine receptors in modulation of systemic and pulmonary hemodynamics in the newborn. Other research has also demonstrated similar results. From preliminary data, Segar pt ul. ( 1 1) have noted changes in hemodynamic variables with infusion of SCH 23390 into chronically instrumented fetal sheep. We have also reported preliminary data demonstrating an increase in pulmonary dopaminergic activity within the I wk of life ofthe rabbit, suggesting a dopaminergic role in the transitional circulation (34) .
Besides the pharmacologic importance, our data from DA, blockade studies suggest a physiologic importance for vascular dopamine receptors. Infusion of SCH 23390 alters systemic and pulmonary hemodynamic variables. These effects may be due to a "turning off' of active vascular vasodilating dopamine receptors. These data. as well as evidence from other studies (9, 1 1 .  15, 30, 34) . suggest that endogenous dopamine and dopamine receptors are active in maintenance of normal hemodynamics in the newborn.
